Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival
出版年份 2019 全文链接
标题
Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival
作者
关键词
-
出版物
Frontiers in Oncology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-09-10
DOI
10.3389/fonc.2019.00874
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Circumventing senescence is associated with stem cell properties and metformin sensitivity
- (2019) Xavier Deschênes-Simard et al. AGING CELL
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice
- (2019) Xiao-Hui Zhao et al. WORLD JOURNAL OF GASTROENTEROLOGY
- High tumor cell vimentin expression indicatesprolonged survival in patients with ovarian malignant tumors
- (2019) Sebastian Szubert et al. Ginekologia Polska
- Retraction notice to “CD133+/CD44+/Oct4+/Nestin+ stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer” [Acta Histochemica 115 (2013) 349–356]
- (2018) Dongqing Wang et al. ACTA HISTOCHEMICA
- Corrigendum to “Clinical impact of circulating tumor cells and therapy response in pancreatic cancer” [43 (6) (2017) 1050–1055]
- (2018) Keishi Okubo et al. EJSO
- Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma
- (2018) Chiara Nicolazzo et al. Analytical Cellular Pathology
- Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival
- (2018) Charles E. Gast et al. Science Advances
- Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward
- (2017) Mohammad Khan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Filtration-based enrichment of circulating tumor cells from all prostate cancer risk groups
- (2017) Julius Adebayo Awe et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Tumacrophage: macrophages transformed into tumor stem-like cells by virulent genetic material from tumor cells
- (2017) Yizhuang Zhang et al. Oncotarget
- Stromal Expression of Vimentin Predicts the Clinical Outcome of Stage II Colorectal Cancer for High-Risk Patients
- (2017) Li-guo Liu et al. MEDICAL SCIENCE MONITOR
- Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma
- (2016) Katherine E. Poruk et al. ANNALS OF SURGERY
- Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells
- (2016) Na Ri Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer
- (2016) J S Ankeny et al. BRITISH JOURNAL OF CANCER
- KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer
- (2016) Karen Bento Ribeiro et al. Cancer Biomarkers
- Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma
- (2016) M.-C. Chang et al. CLINICAL CHEMISTRY
- CTC clusters in cancer progression and metastasis
- (2016) Anna Fabisiewicz et al. MEDICAL ONCOLOGY
- Downregulation of vimentin expression increased drug resistance in ovarian cancer cells
- (2016) Yi Huo et al. Oncotarget
- Pancreatic cancer cell invasion: mesenchymal switch or just hitchhiking?
- (2016) Rémi Samain et al. Translational Cancer Research
- CD44high/ALDH1highhead and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties
- (2015) Sayaka Seino et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Circulating Tumor Cells Found in Patients With Localized and Advanced Pancreatic Cancer
- (2015) Birte Kulemann et al. PANCREAS
- Addressing the challenges of pancreatic cancer: Future directions for improving outcomes
- (2015) Manuel Hidalgo et al. PANCREATOLOGY
- VEGF-B promotes cancer metastasis through a VEGF-A–independent mechanism and serves as a marker of poor prognosis for cancer patients
- (2015) Xiaojuan Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epithelial-Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression
- (2014) A. Satelli et al. CLINICAL CANCER RESEARCH
- Circulating tumour cells in metastatic head and neck cancers
- (2014) Arutha Kulasinghe et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating Tumor Cells as a Biomarker of Response to Treatment in Patient-Derived Xenograft Mouse Models of Pancreatic Adenocarcinoma
- (2014) Robert J. Torphy et al. PLoS One
- Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling
- (2014) Altaf Mohammed et al. Translational Oncology
- Usefulness of Circulating Tumor Cell Detection in Pancreatic Adenocarcinoma Diagnosis
- (2013) Isabelle Iwanicki-Caron et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Circulating tumor cells: Advances in isolation and analysis, and challenges for clinical applications
- (2013) Ramdane Harouaka et al. PHARMACOLOGY & THERAPEUTICS
- Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis
- (2013) Lu Han et al. TUMOR BIOLOGY
- Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery
- (2012) Gregory Sergeant et al. BMC CANCER
- Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer
- (2012) Amir Avan et al. CURRENT PHARMACEUTICAL DESIGN
- A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
- (2011) L Khoja et al. BRITISH JOURNAL OF CANCER
- Vimentin in cancer and its potential as a molecular target for cancer therapy
- (2011) Arun Satelli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidermal Growth Factor Receptor in Pancreatic Cancer
- (2011) Melissa Oliveira-Cunha et al. Cancers
- ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer
- (2010) Xin Hong et al. JOURNAL OF SURGICAL ONCOLOGY
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Suppressive Effects of Vascular Endothelial Growth Factor-B on Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis
- (2010) Imke Albrecht et al. PLoS One
- Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
- (2009) C Kahlert et al. BRITISH JOURNAL OF CANCER
- CD44 and EpCAM: Cancer-Initiating Cell Markers
- (2008) Rachid Marhaba et al. CURRENT MOLECULAR MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started